PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) shares were down 0.9% during trading on Wednesday . The company traded as low as $2.23 and last traded at $2.26. Approximately 3,159 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 36,329 shares. The stock had previously closed at $2.28.
PureTech Health Trading Down 0.9 %
The company has a fifty day moving average of $2.72 and a two-hundred day moving average of $2.58.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 Healthcare Dividend Stocks to Buy
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- The Most Important Warren Buffett Stock for Investors: His Own
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
